Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.24 USD | +1.22% | -5.07% | -51.36% |
05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.36% | 579M | |
+38.74% | 728B | |
+33.05% | 603B | |
-5.44% | 360B | |
+18.86% | 332B | |
+1.49% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.50% | 164B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 03, 2022